Table 2.
Patient ID | Pathology | Zone of Fat Localization | Steatosis % | Steatosis Grade | Inflammation Grade | Ballooning | Fibrosis | Total NAS Score |
---|---|---|---|---|---|---|---|---|
1AFA OV7 | NASH | 3 | 60 | 2 | 2 | 1 | 1a | 5 |
1AF7 OY9 | NASH | 3,2,1 | 70 | 3 | 2 | 2 | 2 | 7 |
1AEU OAT | NASH | 3,2 | 60 | 2 | 1 | 1 | 1a | 4 |
1AFK OKC | NASH | 3 | 25 | 1 | 2 | 0 | 2 | 3 |
1ADW O72 | NASH | 3,2,1; diffuse | 70 | 3 | 1 | 2 | 1a | 6 |
148X O9G | NASH | 3 | 20 | 1 | 2 | 2 | 1a | 5 |
149D OUV | NASH | 3,2 | 40 | 2 | 2 | 1 | 1a | 5 |
148T OD7 | NASH | 3 | 20 | 1 | 2 | 1 | 3 | 4 |
1492 O5E | NASH | 3,2,1 | 70 | 3 | 1 | 1 | 2 | 5 |
Brunt score evaluation of obese nonalcoholic steatohepatitis (NASH) patients based on zone of fat localization, % steatosis, steatosis grade, inflammation grade, ballooning, and fibrosis. NAS, NAFLD Activity Score.